Kenyan Doctor Wins Ksh4 Million Grant
Dr. Njenga will receive a grant of Ksh4 million to carry out her research, together with membership to the French Chamber of Commerce.
Marvin Chege 
La Roche-Posay has announced that a Kenyan doctor, Dr. Winnie Njenga, a dermatologist at the Kiambu Level 5 Hospital is the first African winner of its annual Research Grants.
Her project on “The quality of life in children, teenagers and adults diagnosed with eczema in Kenya,” satisfied the grants’ high-ranking jury of dermatologists drawn from around the world as one that will provide valuable data and insights on how skin conditions affect the quality of life of patients in different parts of the country.
Dr. Njenga will receive a grant of Ksh4 million to carry out her research, together with membership to the French Chamber of Commerce.
“La Roche-Posay partners with dermatologists worldwide to stay at the forefront of skin science research and to formulate safe and effective products that are dermatologist-developed and tested.
Left to Right: L’Oréal Dermatological Beauty East Africa General Manager Edouard Homasson, Dr Winnie Njenga, winner of the La Roche-Posay Research Grants and L’Oréal East Africa Managing Director Yassine Bakkari at the awarding ceremony in Nairobi on October 3, 2023. /PHOTO.COURTESY
"We’re proud that this year’s winner is a Kenyan doctor who also happens to be the first African to win the grant to further her research project which shows immense potential for improving the lives of dermatological patients in Kenya,” L’Oréal East Africa Managing Director Yassine Bakkari said.
In its 28th edition, the La Roche-Posay Research Grant is a global initiative to support research in dermatology worldwide, with more than 200 leading researchers around the world already benefitting from the grants.
This year, hundreds of dermatologists leading research in the quality of life of patients competed to win prestigious grants, from the four big regions of the world - Africa, Asia, Europe and Latin America.
“These grants aim to address the impact of dermatological issues on the quality of life of patients and as La Roche-Posay, we are heavily committed to fueling the next generation of dermatologists in Kenya and Africa who form an integral part of how we develop products with high efficacy that work for the African skin,” said Edouard Homasson, L’Oréal Dermatological Beauty Division General Manager.
With this new edition of the grants, La Roche-Posay reinforces its commitment to research to improve patient’s quality of life by encouraging a better understanding of skin conditions and driving research towards optimal dermatological solutions.
Recommended by 90,000 dermatologists worldwide, La Roche-Posay's mission is to offer life-changing dermatological skincare and a unique range of daily skincare developed for every skin type to address various skin concerns and complement prescription treatments.
At the centre of the brand is the exclusive selenium-rich La Roche-Posay Thermal Spring Water, a core ingredient in its skincare formulas known for its soothing and antioxidant properties that is sourced from its Thermal Center in France, the first Dermatology Center in Europe.
The products are developed using a strict safety and formulation charter with a minimal number of ingredients and are formulated at optimal concentrations.
Additionally, La Roche-Posay products undergo stringent clinical testing for efficacy and safety with over 750+ studies and 25 years of extensive research, even on sensitive skin.
